These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

669 related articles for article (PubMed ID: 11958396)

  • 1. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Pinede L, Ninet J, Duhaut P et al for the Investigators of the 'Durée Optimale du Traitement Antivitamines K' (DOTAVK) study. Circulation 2001; 103: 2453-60.
    Anand SS
    Vasc Med; 2001 Nov; 6(4):269-70. PubMed ID: 11958396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis.
    Pinede L; Ninet J; Duhaut P; Chabaud S; Demolombe-Rague S; Durieu I; Nony P; Sanson C; Boissel JP;
    Circulation; 2001 May; 103(20):2453-60. PubMed ID: 11369685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of recurrent venous thromboembolism in patients with unprovoked symptomatic deep vein thrombosis and asymptomatic pulmonary embolism.
    Jiménez D; Díaz G; Marín E; Vidal R; Sueiro A; Yusen RD
    Thromb Haemost; 2006 Mar; 95(3):562-6. PubMed ID: 16525588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Anticoagulation for Isolated Calf Deep Vein Thrombosis.
    Utter GH; Dhillon TS; Salcedo ES; Shouldice DJ; Reynolds CL; Humphries MD; White RH
    JAMA Surg; 2016 Sep; 151(9):e161770. PubMed ID: 27437827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study.
    Kyrle PA; Kammer M; Eischer L; Weltermann A; Minar E; Hirschl M; Heinze G; Eichinger S
    J Thromb Haemost; 2016 Dec; 14(12):2402-2409. PubMed ID: 27696701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism.
    Kovacs MJ; Kahn SR; Wells PS; Anderson DA; Chagnon I; LE Gal G; Solymoss S; Crowther M; Perrier A; Ramsay T; Betancourt MT; White RH; Vickars L; Rodger MA
    J Thromb Haemost; 2010 Sep; 8(9):1926-32. PubMed ID: 20561184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The controversy of managing calf vein thrombosis.
    Masuda EM; Kistner RL; Musikasinthorn C; Liquido F; Geling O; He Q
    J Vasc Surg; 2012 Feb; 55(2):550-61. PubMed ID: 22032881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double-blind, placebo-controlled trial.
    Righini M; Galanaud JP; Guenneguez H; Brisot D; Diard A; Faisse P; Barrellier MT; Hamel-Desnos C; Jurus C; Pichot O; Martin M; Mazzolai L; Choquenet C; Accassat S; Robert-Ebadi H; Carrier M; Le Gal G; Mermilllod B; Laroche JP; Bounameaux H; Perrier A; Kahn SR; Quere I
    Lancet Haematol; 2016 Dec; 3(12):e556-e562. PubMed ID: 27836513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of pulmonary embolism in patients with proximal deep vein thrombosis: specificity of symptoms and perfusion defects at baseline and during anticoagulant therapy.
    Girard P; Decousus M; Laporte S; Buchmuller A; Hervé P; Lamer C; Parent F; Tardy B;
    Am J Respir Crit Care Med; 2001 Sep; 164(6):1033-7. PubMed ID: 11587992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation in patients with isolated distal deep vein thrombosis: a meta-analysis.
    Franco L; Giustozzi M; Agnelli G; Becattini C
    J Thromb Haemost; 2017 Jun; 15(6):1142-1154. PubMed ID: 28316124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should patients with deep vein thrombosis alone be treated as those with concomitant asymptomatic pulmonary embolism? A prospective study.
    Monreal M; Büller H; Lensing AW; Bonet M; Roncales J; Muchart J; Fraile M
    Thromb Haemost; 2002 Dec; 88(6):938-42. PubMed ID: 12529742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical course of patients with symptomatic isolated superficial vein thrombosis: the ICARO follow-up study.
    Barco S; Pomero F; Di Minno MND; Tamborini Permunian E; Malato A; Pasca S; Barillari G; Fenoglio L; Siragusa S; Di Minno G; Ageno W; Dentali F
    J Thromb Haemost; 2017 Nov; 15(11):2176-2183. PubMed ID: 28871623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of pulmonary embolism in patients with isolated calf deep vein thrombosis.
    Wu AR; Garry J; Labropoulos N
    J Vasc Surg Venous Lymphat Disord; 2017 Mar; 5(2):274-279. PubMed ID: 28214497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term risk of venous thromboembolism recurrence after isolated superficial vein thrombosis.
    Galanaud JP; Sevestre MA; Pernod G; Kahn SR; Genty C; Terrisse H; Brisot D; Gillet JL; Quéré I; Bosson JL
    J Thromb Haemost; 2017 Jun; 15(6):1123-1131. PubMed ID: 28317330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.
    Ageno W; Mantovani LG; Haas S; Kreutz R; Monje D; Schneider J; van Eickels M; Gebel M; Zell E; Turpie AG
    Lancet Haematol; 2016 Jan; 3(1):e12-21. PubMed ID: 26765643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of patients with acute deep vein thrombosis and/or pulmonary embolism: efficacy and safety of non-VKA oral anticoagulants in selected populations.
    Prandoni P
    Thromb Res; 2014 Aug; 134(2):227-33. PubMed ID: 24875390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism.
    Kearon C; Akl EA
    Blood; 2014 Mar; 123(12):1794-801. PubMed ID: 24497538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enoxaparin in the treatment of deep vein thrombosis with or without pulmonary embolism: an individual patient data meta-analysis.
    Mismetti P; Quenet S; Levine M; Merli G; Decousus H; Derobert E; Laporte S
    Chest; 2005 Oct; 128(4):2203-10. PubMed ID: 16236875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profile of Patients with Isolated Distal Deep Vein Thrombosis versus Proximal Deep Vein Thrombosis or Pulmonary Embolism: RE-COVERY DVT/PE Study.
    Schellong S; Ageno W; Casella IB; Chee KH; Schulman S; Singer DE; Desch M; Tang W; Voccia I; Zint K; Goldhaber SZ
    Semin Thromb Hemost; 2022 Jun; 48(4):446-458. PubMed ID: 33971682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin therapy associated with improved thrombus resolution in patients with deep vein thrombosis.
    Hsu C; Brahmandam A; Brownson KE; Huynh N; Reynolds J; Lee AI; Fares WH; Ochoa Chaar CI
    J Vasc Surg Venous Lymphat Disord; 2019 Mar; 7(2):169-175.e4. PubMed ID: 30660579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.